Dan Li

US Patent:

8470203, Jun 25, 2013

Filed:

Mar 15, 2010

Appl. No.:

12/724252

Inventors:

Richard B. Kaner - Pacific Palisades CA, US
Dan Li - Seattle WA, US
Jiaxing Huang - Berkeley CA, US

Assignee:

The Regents of the University of California - Oakland CA

International Classification:

H01B 1/00
C08G 73/00
B05D 5/12

US Classification:

252500, 528422, 427 58

Abstract:

A new method for forming stable polyaniline nanofiber colloids uses electrostatic repulsion to maintain dispersion of the nanofibers and prevent aggregation during synthesis of the nanofibers. The colloidal suspensions are formed directly from the reactants in solution maintained at a pH of about 1. 0 to about 4. 0 and a temperature of about 10 C. to about 100 C. with minimal or no stirring. Also set forth are new methods for forming ultrathin films of polyaniline nanofibers via self-assembly.

US Patent:

20050181374, Aug 18, 2005

Filed:

Jan 5, 2004

Appl. No.:

10/752079

Inventors:

Scott Friedman - Scarsdale NY, US
Dan Li - New York NY, US
Goutham Narla - New York NY, US
John Martignetti - Chappaqua NY, US
Karen Heath - Madrid, ES

Assignee:

Mount Sinai School of Medicine of New York University - New York NY

International Classification:

C12Q001/68
G01N033/53
G01N033/567

US Classification:

435006000, 435007200

Abstract:

The present invention relates to identification of tumor suppressor activity of a protein, KLF6 (KLF6), and to related diagnostic and therapeutic compositions and methods. The discovery of this tumor suppressor activity provides screening targets as well, particularly screening for compounds that overcome gene inactivation or alteration.

US Patent:

20070194286, Aug 23, 2007

Filed:

Feb 17, 2006

Appl. No.:

11/356790

Inventors:

Richard Kaner - Pacific Palisades CA, US
Dan Li - Seattle WA, US
Jiaxing Huang - Berkeley CA, US

International Classification:

H01B 1/12

US Classification:

252500000

Abstract:

A new method for forming stable polyaniline nanofiber colloids uses electrostatic repulsion to maintain dispersion of the nanofibers and prevent aggregation during synthesis of the nanofibers. The colloidal suspensions are formed directly from the reactants in solution maintained at a pH of about 1.0 to about 4.0 and a temperature of about 10 C. to about 100 C. with minimal or no stirring. Also set forth are new methods for forming ultrathin films of polyaniline nanofibers via self-assembly.

US Patent:

20110059899, Mar 10, 2011

Filed:

Apr 28, 2010

Appl. No.:

12/769595

Inventors:

Scott Friedman - Scarsdale NY, US
Dan Li - Arlington MA, US
Goutham Narla - New Rochelle NY, US
John Martignetti - Chappaqua NY, US
Karen Heath - Madrid, ES

Assignee:

Mount Sinai School of Medicine of New York University - New York NY

International Classification:

A61K 38/17
A61K 31/7088
A61P 35/00
C12Q 1/68
G01N 33/53
C12Q 1/48
C12Q 1/28
C12N 5/02
C12N 15/63

US Classification:

514 193, 514 44 R, 435 6, 435 71, 435 15, 435 28, 435375, 4353201

Abstract:

The present invention relates to identification of tumor suppressor activity of a protein, KLF6 (KLF6), and to related diagnostic and therapeutic compositions and methods. The discovery of this tumor suppressor activity provides screening targets as well, particularly screening for compounds that overcome gene inactivation or alteration.

US Patent:

20130331919, Dec 12, 2013

Filed:

Aug 12, 2013

Appl. No.:

13/964807

Inventors:

Haresh G. Sachanandani - Culver City CA, US
Dan Li - Shoreview MN, US
Bin Mi - Plymouth MN, US

Assignee:

Cardiac Pacemakers, Inc. - St. Paul MN

International Classification:

A61N 1/05

US Classification:

607119

Abstract:

Various implantable medical device embodiments stimulate an autonomic neural target from within a pulmonary artery, and comprise at least one electrode, a power supply, a neural stimulator connected to the power supply, and an anchor structure. The neural stimulator is configured to generate a neural stimulation signal for delivery to the neural stimulation target through the at least one electrode. The anchor structure is configured to chronically and securely implant the neural stimulator, the power supply and the at least one electrode within the pulmonary artery. The anchor structure, the neural stimulator, the power supply and the at least one electrode are configured to be implanted through a pulmonary valve into the pulmonary artery. In various embodiments, the neural stimulator is configured to be operational to implement a neural stimulation protocol when chronically implanted within the pulmonary artery without a wired connection through the pulmonary valve.

US Patent:

20150297760, Oct 22, 2015

Filed:

Mar 15, 2013

Appl. No.:

14/438863

Inventors:

Peter S. CONTI - Pasadena CA, US
Zibo LI - , US
Shuanglong LIU - , US
Dan LI - Los Angeles CA, US

Assignee:

University of Southern California - Los Angeles CA

International Classification:

A61K 51/04
A61B 6/03
A61K 49/00
A61B 5/00

Abstract:

This invention provides a class of dual mode imaging tracer capable of acting both as a fluorescent imaging tracer and a positron emission tomography imaging tracer. Tracers in accordance with this invention generally have a fluorescent core with a boron-fluoride element embedded therein. Exemplary embodiments of the tracer include F-labeled BODIPY compounds and derivative thereof. Also provided are tracer kits containing a sterile formulation of a BODIPY dye either in a radio-labeled or pre-labeled state, and methods for imaging heart perfusion using the F-labeled dual mode tracers.